Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1993;44(2):177-82.
doi: 10.1007/BF00315477.

Pharmacodynamic model of the haemodynamic effects of pinacidil in normotensive volunteers

Affiliations
Clinical Trial

Pharmacodynamic model of the haemodynamic effects of pinacidil in normotensive volunteers

P Girard et al. Eur J Clin Pharmacol. 1993.

Abstract

The concentration-effect relationships of pinacidil, a peripheral vasodilator, have been measured in 12 healthy adults who received placebo or pinacidil 25 mg daily for 1 week in a cross-over experiment. Diastolic blood pressure (DBP) and heart rate (HR) were recorded and blood samples were taken on days 1 and 7. Plasma drug concentration-time data were fitted by a biexponential function with zero-order input. The pharmacokinetic model was incorporated into a combined pharmacokinetic-dynamic model (PK-PD) using the Hill equation, which has three parameters: n, the sigmoidicity parameter, Emax the maximum effect and EC50 the concentration which gives 50% of Emax. For delta DBP, the parameter medians were estimated as n = 5, EC50 = 44.6 ng.ml-1 and Emax = 13.5 mmHg. A hysteresis loop was found when delta HR was plotted against concentration, which could be fitted by a linear effect compartment model. Simulations showed that experimental delta DBP points on Day 7 could be predicted from a simulated curve computed by the model using parameters estimated on Day 1. Using the simulation, it was possible to suggest an optimal dosage regimen for pinacidil tablets.

PubMed Disclaimer

References

    1. Clin Pharmacokinet. 1981 Nov-Dec;6(6):429-53 - PubMed
    1. Br J Pharmacol. 1987 Jun;91(2):421-9 - PubMed
    1. Br J Clin Pharmacol. 1991 Jan;31(1):33-9 - PubMed
    1. Eur J Pharmacol. 1983 Apr 8;88(4):389-92 - PubMed
    1. Br J Clin Pharmacol. 1985 Jan;19(1):91-4 - PubMed

Publication types

LinkOut - more resources